Diagnostic Criteria for Osteoporosis Should Be Expanded

Overview

Journal Lancet Diabetes Endocrinol

Specialty Endocrinology

Date 2015 Mar 24

PMID 25797769

Citations 4

Authors

Alexandra Papaioannou

Courtney Kennedy

Affiliations

Soon will be listed here.

Citing Articles

A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study.

Arboleya L, Cancio-Trujillo J, Chaves C, Duaso-Magana E, Mesa-Ramos M, Olmos J Arch Osteoporos. 2023; 18(1):110.

PMID: 37610481 PMC: 10447260. DOI: 10.1007/s11657-023-01318-7.

Fragility Fractures and Imminent Fracture Risk in the Spanish Population: A Retrospective Observational Cohort Study.

Montoya-Garcia M, Giner M, Marcos R, Garcia-Romero D, Olmo-Montes F, Miranda M J Clin Med. 2021; 10(5).

PMID: 33807710 PMC: 7961522. DOI: 10.3390/jcm10051082.

Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength.

Beck-Cormier S, Lelliott C, Logan J, Lafont D, Merametdjian L, Leitch V J Bone Miner Res. 2019; 34(6):1101-1114.

PMID: 30721528 PMC: 6618161. DOI: 10.1002/jbmr.3691.

Anabolic Therapies in Osteoporosis and Bone Regeneration.

Russow G, Jahn D, Appelt J, Mardian S, Tsitsilonis S, Keller J Int J Mol Sci. 2018; 20(1).

PMID: 30587780 PMC: 6337474. DOI: 10.3390/ijms20010083.

References

Papaioannou A, Morin S, Cheung A, Atkinson S, Brown J, Feldman S . 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010; 182(17):1864-73. PMC: 2988535. DOI: 10.1503/cmaj.100771. View

Kanis J, McCloskey E, Johansson H, Oden A, Leslie W . FRAX(®) with and without bone mineral density. Calcif Tissue Int. 2011; 90(1):1-13. DOI: 10.1007/s00223-011-9544-7. View

Barratt A, Wyer P, Hatala R, McGinn T, Dans A, Keitz S . Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ. 2004; 171(4):353-8. PMC: 509050. DOI: 10.1503/cmaj.1021197. View

Kanis J . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994; 4(6):368-81. DOI: 10.1007/BF01622200. View

Gehlbach S, Saag K, Adachi J, Hooven F, Flahive J, Boonen S . Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2011; 27(3):645-53. PMC: 4881741. DOI: 10.1002/jbmr.1476. View

Greenspan S, Perera S, Nace D, Zukowski K, Ferchak M, Lee C . FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities. J Am Geriatr Soc. 2012; 60(4):684-90. PMC: 3477847. DOI: 10.1111/j.1532-5415.2011.03884.x. View

Sornay-Rendu E, Munoz F, Duboeuf F, Delmas P . Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res. 2005; 20(11):1929-35. DOI: 10.1359/JBMR.050704. View

Felsenberg D, Boonen S . The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. 2005; 27(1):1-11. DOI: 10.1016/j.clinthera.2004.12.020. View

Quandt S, Thompson D, Schneider D, Nevitt M, Black D . Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005; 80(3):343-9. DOI: 10.4065/80.3.343. View

10.

Kanis J . An update on the diagnosis of osteoporosis. Curr Rheumatol Rep. 2000; 2(1):62-6. DOI: 10.1007/s11926-996-0070-y. View

11.

Schuit S, van der Klift M, Weel A, de Laet C, Burger H, Seeman E . Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34(1):195-202. DOI: 10.1016/j.bone.2003.10.001. View